Table 1.

Prenatal diagnosis carried out by PCR and antigenemia testing with FB and by PCR and rapid virus isolation with AF in relation to outcome for fetus or newborn for pregnant women at risk of transmitting a CMV infection and control populationa

GroupFBAF
Total no. of specimensNo. of specimens positive by PCRNo. of specimens positive by AG testingInfected fetus or newbornTotal no. of specimensNo. of specimens positive by PCRNo. of specimens positive by SVInfected fetus or newborn
Fetus/newbornbTotal no.Fetus/newbornTotal no.
Seroconversion for CMV IgG10210/1116911/34
IgM positivity by ELISA391012/35611443/36
Clinical symptoms (mother/fetus)100005411/12
Total501222/46822555/712
Uninfected (EIA IgM negative)110000200000
  • a AG, antigenemia; SV, shell vial assay.

  • b Number of infected fetuses/number of infected newborns.